12 | PolymersIBA
11/2013
-
03/2002 |
5 | Proteins (Proteins, Gene)FDA Link
01/2021
-
08/2008 |
5 | Peptides (Polypeptides)IBA
09/2020
-
01/2006 |
5 | LigandsIBA
02/2013
-
10/2006 |
3 | AntigensIBA
01/2021
-
11/2010 |
3 | CytokinesIBA
01/2021
-
12/2011 |
3 | Monoclonal AntibodiesIBA
09/2020
-
03/2011 |
3 | EpitopesIBA
09/2020
-
01/2016 |
3 | Messenger RNA (mRNA)IBA
05/2019
-
08/2008 |
3 | VaccinesIBA
10/2016
-
01/2016 |
3 | E-SelectinIBA
02/2013
-
03/2011 |
3 | Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009
-
03/2002 |
2 | Single-Chain AntibodiesIBA
01/2021
-
11/2010 |
2 | DNA (Deoxyribonucleic Acid)IBA
01/2021
-
04/2009 |
2 | Membrane Proteins (Integral Membrane Proteins)IBA
09/2020
-
01/2019 |
2 | Pharmaceutical PreparationsIBA
05/2019
-
11/2013 |
2 | Neutralizing AntibodiesIBA
10/2016
-
03/2009 |
2 | Liposomes (Liposome)IBA
02/2013
-
10/2006 |
2 | LuciferasesIBA
03/2011
-
03/2003 |
2 | MicroRNAs (MicroRNA)IBA
01/2011
-
05/2009 |
2 | Green Fluorescent ProteinsIBA
04/2009
-
03/2003 |
2 | Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2009
-
04/2008 |
2 | ErbB Receptors (EGF Receptor)IBA
03/2009
-
02/2008 |
2 | Epidermal Growth Factor (EGF)IBA
03/2009
-
02/2008 |
2 | OligopeptidesIBA
10/2006
-
01/2006 |
1 | HLA Antigens (Human Leukocyte Antigens)IBA
02/2021 |
1 | Interferon-gamma (Interferon, gamma)IBA
01/2021 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 |
1 | Chimeric Antigen ReceptorsIBA
01/2021 |
1 | Immune Checkpoint InhibitorsIBA
01/2021 |
1 | Immune Checkpoint ProteinsIBA
01/2021 |
1 | T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021 |
1 | B7-H1 AntigenIBA
01/2021 |
1 | AntibodiesIBA
09/2020 |
1 | pertuzumabIBA
09/2020 |
1 | OvalbuminIBA
09/2020 |
1 | Cancer VaccinesIBA
01/2020 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2019 |
1 | Adenosine Triphosphate (ATP)IBA
01/2019 |
1 | Glutamine (L-Glutamine)FDA Link
01/2019 |
1 | Biological ProductsIBA
01/2018 |
1 | Antineoplastic Agents (Antineoplastics)IBA
01/2018 |
1 | HMGB1 Protein (HMG1)IBA
03/2017 |
1 | Interleukin-6 (Interleukin 6)IBA
03/2017 |
1 | Epithelial Cell Adhesion MoleculeIBA
01/2017 |
1 | Deoxyribonuclease I (Nickase)IBA
04/2016 |
1 | Endopeptidase K (Proteinase K)IBA
04/2016 |
1 | EnzymesIBA
04/2016 |
1 | Chondroitin ABC LyaseIBA
04/2016 |
1 | Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
04/2016 |
1 | Deoxyribonucleases (DNase)FDA Link
04/2016 |
1 | GoldIBA
01/2016 |
1 | Viral AntigensIBA
01/2016 |
1 | T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2016 |
1 | DuxonIBA
11/2013 |
1 | Glycoproteins (Glycoprotein)IBA
02/2013 |
1 | LuciferinsIBA
02/2013 |
1 | SelectinsIBA
02/2013 |
1 | P-SelectinIBA
02/2013 |
1 | Viral VaccinesIBA
09/2012 |
1 | Y 27632IBA
12/2011 |
1 | rho-Associated KinasesIBA
12/2011 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2011 |
1 | methacrylamideIBA
03/2011 |
1 | Synthetic Vaccines (Recombinant Vaccines)IBA
02/2010 |
1 | N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA
06/2009 |
1 | AnthracyclinesIBA
06/2009 |
1 | Attenuated VaccinesIBA
05/2009 |
1 | Factor X (Stuart Factor)IBA
04/2009 |
1 | 1,1'- ((4,4,7,7- tetramethyl)- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- oxazole)- 2- methylidene)quinolinium (YOYO)IBA
04/2009 |
1 | Texas redIBA
04/2009 |
1 | Cetuximab (Erbitux)FDA Link
03/2009 |
1 | adenovirus receptorIBA
02/2009 |
1 | Surface Antigens (Surface Antigen)IBA
08/2008 |